Self-healing isn't only the domain of the computer industry, its also being developed for the human body.
Scientists at the University of Toronto in collaboration with the Toronto Recombinant Antibody Centre, developed antibodies that in the future could be used to stimulate tissue in the body to repair itself.
The research, published in eLife, is the result of ten years of work between teams of scientists led by Sachdev Sidhu, a professor in the Donnelly Centre for Cellular and Biomolecular Research, and Stephane Angers, Associate Dean of Research in the Leslie Dan Faculty of Pharmacy.
"We are developing new molecules that have never been seen before and whose potential for regenerative medicine is enormous," says Sidhu in a press release highlighting the work. "By capitalizing on the momentum of stem cells research and regenerative medicine that already exists in Toronto, we are ideally situated to commercialize these molecules." AntierA Therapeutics, a new startup in Toronto will take the antibodies and develop drug-like molecules to be applied to regenerative medicine.
To read more, click here.